GSK926
GSK926 is a potent, cell-permeable small molecule inhibitor that selectively targets EZH2 by competing with its cofactor SAM. It is utilized in epigenetic research to investigate histone methylation roles in cancer biology, demonstrating activity in both cellular and animal models of lymphoma.
Product Specifications
CAS Number
1346704-13-9
Field of Research
Epigenetics & Chromatin
Smiles
C (C) (C) N1C=2C (=C (C (NCC3=C (C) C=C (C) NC3=O) =O) C=C (C2) C=4C=CC (=NC4) N5CCN (C) CC5) C=N1
Molecular Formula
C29H35N7O2
Molecular Weight
513.63
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1367596-01 0.05 mg (E-Coli)
Recombinant Cryptococcus neoformans var. neoformans serotype D Inosine triphosphate pyrophosphatase (CNA03000)
Sign In for Pricing
View Details MBS1367596-02 0.05 mg (Yeast)
Recombinant Cryptococcus neoformans var. neoformans serotype D Inosine triphosphate pyrophosphatase (CNA03000)
Sign In for Pricing
View Details 
MBS1367596-03 0.2 mg (E-Coli)
Recombinant Cryptococcus neoformans var. neoformans serotype D Inosine triphosphate pyrophosphatase (CNA03000)
Sign In for Pricing
View Details MBS1367596-04 0.5 mg (E-Coli)
Recombinant Cryptococcus neoformans var. neoformans serotype D Inosine triphosphate pyrophosphatase (CNA03000)
Sign In for Pricing
View Details MBS1367596-05 0.05 mg (Baculovirus)
Recombinant Cryptococcus neoformans var. neoformans serotype D Inosine triphosphate pyrophosphatase (CNA03000)
Sign In for Pricing
View Details MBS1367596-06 0.2 mg (Yeast)
Recombinant Cryptococcus neoformans var. neoformans serotype D Inosine triphosphate pyrophosphatase (CNA03000)
Sign In for Pricing
View Details